Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Miranda Moskie"'
Autor:
Hassana el Haddaoui, Rianne Brood, Diba Latifi, Astrid A. Oostvogels, Yarne Klaver, Miranda Moskie, Dana A. Mustafa, Reno Debets, Casper H. J. van Eijck
Publikováno v:
Cancers, Vol 14, Iss 6, p 1377 (2022)
Background: Treatment with the TLR-3 agonist rintatolimod may improve pancreatic cancer patients’ survival via immunomodulation, but the effect is unproven. Methods: In this single-center named patient program, patients with locally advanced pancre
Externí odkaz:
https://doaj.org/article/70b27b0897f34106a7fdf714f94f8e6a
Autor:
Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd H. van der Burg, Casper H.J. van Eijck, Dana A.M. Mustafa
Publikováno v:
European Journal of Cancer, 181, 119-134. ELSEVIER SCI LTD
European Journal of Cancer, 181, 119-134. Elsevier Ltd.
European Journal of Cancer, 181, 119-134. Elsevier Ltd.
Introduction: 5-fluorouracil, folinic acid, irinotecan and oxaliplatin (FOLFIRINOX) is promising in treating patients with pancreatic ductal adenocarcinoma. However, many patients and physicians are reluctant to start FOLFIRINOX due to its high toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0847fb2604c6d845e26442df33b96385
https://hdl.handle.net/1887/3566769
https://hdl.handle.net/1887/3566769
Autor:
Monique van Dijk, Miranda Moskie, Laura Schafthuizen, Freek R. van ’t Land, Fleur van der Sijde, Hanneke W. M. van Laarhoven, Casper H.J. van Eijck
Publikováno v:
Supportive Care in Cancer
Supportive care in cancer, 30(3), 2407-2415. Springer Verlag
Supportive Care in Cancer, 30(3), 2407-2415. Springer-Verlag
Supportive care in cancer, 30(3), 2407-2415. Springer Verlag
Supportive Care in Cancer, 30(3), 2407-2415. Springer-Verlag
Background Quality of life in cancer patients might be affected by chemotherapy-induced toxicity. Especially in patients with pancreatic ductal adenocarcinoma (PDAC), with a short life expectancy, fear of poor quality of life is often a reason for bo
Autor:
Hassana, El Haddaoui, Rianne, Brood, Diba, Latifi, Astrid A, Oostvogels, Yarne, Klaver, Miranda, Moskie, Dana A, Mustafa, Reno, Debets, Casper H J, van Eijck
Publikováno v:
Cancers. 14(6)
Treatment with the TLR-3 agonist rintatolimod may improve pancreatic cancer patients' survival via immunomodulation, but the effect is unproven.In this single-center named patient program, patients with locally advanced pancreatic cancer (LAPC) or me
Autor:
Casper W.F. van Eijck, Willem de Koning, Fleur van der Sijde, Miranda Moskie, Bas Groot Koerkamp, Marjolein Y.V. Homs, Sjoerd. H. van der Burg, Casper H.J. van Eijck, Dana A.M. Mustafa
Publikováno v:
SSRN Electronic Journal.
Introduction: FOLFIRINOX chemotherapy showed promising results in treating patients with pancreatic ductal adenocarcinoma (PDAC). However, many patients and physicians are reluctant to start FOLFIRINOX due to its high toxicity and limited clinical re